Aspen Aerogels, Inc.
ASPNBasic MaterialsNASDAQSpecialty Chemicals · Last scanned Sep 8, 2026
Scan Results
Daily timeframeAspen Aerogels, Inc., an aerogel technology company, designs, develops, manufactures, and sells aerogel materials primarily for use in the energy industrial, sustainable insulation materials, and. The company carries a $408.3M market cap, placing it firmly in the small-cap category. It operates through two segments: Thermal Barrier and Energy Industrial.
Market Cap
$408.3M
Beta
2.97
P/E (TTM)
—
P/E (Fwd)
-31.74
EPS (TTM)
$-1.52
EPS (Fwd)
$-0.15
ROE
-50.4%
ROA
-8.5%
Cash
$151.7M
Total Debt
$125.1M
Free CF
$44.1M
52W Change
-26.1%
Annual Financials
Cash vs Debt
Where ASPN stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, ASPN finished 7.66% above its 150-day moving average ($4.57) and 16.04% above its 200-day moving average ($4.24). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is ASPN overbought or oversold?
At the September 3, 2026 close, ASPN's RSI(14) was 20.8, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $151.7M in cash and $125.1M in debt, ASPN maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. The company generates $44.1M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of -50.4% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $180.4M (2022) to $271.1M (2025), reflecting a 50% increase over the period.
Aspen Aerogels, Inc.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. No single metric tells the full story. Reviewing ASPN's risk profile alongside its fundamentals and technical indicators provides a more complete picture.